Quick Takeaways: Why It Matters? Merck Animal Health is doubling down on biodevices and automation in poultry by buying TARGAN, turning from a strategic investor into full owner of high-speed sexing and precision vaccination tech Source: Businesswire...
Quick Takeaways: Why It Matters? Ceva is using this deal to cement a differentiated position in swine health by owning Europe’s only commercial vaccine against swine dysentery, a disease that drives major losses in pig production. This will also deepen Ceva’s R&D pipeline and...
Quick Takeaways: Why It Matters? Viyash is using BioForLife as a front-end platform to scale its companion animal business in Europe, starting with Italy, one of the continent’s largest and fastest-growing pet health markets. Market-wise, the all-cash ...
Quick Takeaways: Why It Matters? The VievePharm deal gives Zenex a certified Western European manufacturing and sales base plus advanced bolus technology, accelerating its shift from an India‑focused player to a global naturals-led animal health company alig...
